MADISON, N.J., April 6, 2011 /PRNewswire/ — Quest Diagnostics
Incorporated (NYSE:
DGX), the world’s leading provider of diagnostic testing,
information and services, today announced that the Simplexa™
molecular test on the 3M™ Integrated Cycler was honored with
a bronze award for best new science and medical diagnostic product
during the 2011 Edison Awards gala ceremony last night in New York
City. Focus Diagnostics, the infectious disease diagnostics
business of Quest Diagnostics, developed and provides the Simplexa
line of molecular test products to laboratories internationally in
collaboration with 3M.
“Passion for developing diagnostic innovations that will improve
patient care is central to our culture and mission,” said Surya N.
Mohapatra, Ph.D., chairman and chief executive officer, Quest
Diagnostics. “Winning the prestigious Edison award
underscores the strength of our commitment to innovation and
our patients while also marking the success of our close
collaboration with 3M.”
The Edison awards, named after the prolific inventor Thomas Alva
Edison, are granted under the aegis of the Thomas A. Edison Papers
at Rutgers University and sponsored by The Nielsen Company and
Discovery Channel, among other companies. More than 2,000
marketing professionals and academics with the Marketing Executives
Networking Group (MENG) select the best products based on criteria
that include technological innovation, and market and social
impact, and marketplace success. Last night’s winners include the
Apple iPad, the GE energy smart LED A19 Bulb, and Coca-Cola
Freestyle®. For a complete list of winners, refer to: http://www.edisonawards.com/MediaRoom.php
“Fast, quality test reporting is vital to patient care. The
Edison award underscores the significance of the Simplexa and
3M
‘/>”/>
